$0
Infinity Pharmaceuticals is a biotechnology business based in the US. Infinity Pharmaceuticals shares (INFI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Infinity Pharmaceuticals employs 30 staff and has a trailing 12-month revenue of around $2.6 million.
What's in this guide?
Our top picks for where to buy Infinity Pharmaceuticals stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Infinity Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – INFI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Infinity Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Infinity Pharmaceuticals stock price (NASDAQ: INFI)
Use our graph to track the performance of INFI stocks over time.Infinity Pharmaceuticals shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.01 |
50-day moving average | $0.06 |
200-day moving average | $0.23 |
Wall St. target price | $0.30 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.44 |
Is it a good time to buy Infinity Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Infinity Pharmaceuticals price performance over time
Historical closes compared with the close of $0 from 2023-12-20
1 week (2024-10-12) | N/A |
---|---|
1 month (2024-09-19) | N/A |
3 months (2024-07-19) | N/A |
6 months (2024-04-19) | N/A |
1 year (2023-10-23) | -100.00% |
---|---|
2 years (2022-10-21) | -100.00% |
3 years (2021-10-22) | 2.59 |
5 years (2019-10-23) | 1.1 |
Infinity Pharmaceuticals financials
Revenue TTM | $2.6 million |
---|---|
Gross profit TTM | $-31,381,000 |
Return on assets TTM | -60.7% |
Return on equity TTM | -3521.35% |
Profit margin | 0% |
Book value | $-0.41 |
Market Capitalization | $726,088 |
TTM: trailing 12 months
Infinity Pharmaceuticals share dividends
We're not expecting Infinity Pharmaceuticals to pay a dividend over the next 12 months.
Have Infinity Pharmaceuticals's shares ever split?
Infinity Pharmaceuticals's shares were split on a 1:4 basis on 12 September 2006 . So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Infinity Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Infinity Pharmaceuticals shares which in turn could have impacted Infinity Pharmaceuticals's share price.
Infinity Pharmaceuticals share price volatility
Over the last 12 months, Infinity Pharmaceuticals's shares have ranged in value from as little as $0.0027 up to $0.0054. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Infinity Pharmaceuticals's is 1.3804. This would suggest that Infinity Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Infinity Pharmaceuticals overview
Infinity Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc.
Frequently asked questions
nullWhat percentage of Infinity Pharmaceuticals is owned by insiders or institutions?
Currently 2.356% of Infinity Pharmaceuticals shares are held by insiders and 23.485% by institutions. How many people work for Infinity Pharmaceuticals?
Latest data suggests 30 work at Infinity Pharmaceuticals. When does the fiscal year end for Infinity Pharmaceuticals?
Infinity Pharmaceuticals's fiscal year ends in December. Where is Infinity Pharmaceuticals based?
Infinity Pharmaceuticals's address is: 1100 Massachusetts Avenue, Cambridge, MA, United States, 02138 What is Infinity Pharmaceuticals's ISIN number?
Infinity Pharmaceuticals's international securities identification number is: US45665G3039 What is Infinity Pharmaceuticals's CUSIP number?
Infinity Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 254675101
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com review 2024: No-fee options with rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question